Skip to main content

Table 3 Cox regression of predictors of mortality in lupus patients from the RELESSER-TRANS cohort

From: Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort

 

Hazard ratio

95% confidence interval

P value

Pleuropulmonary manifestations

3.13

1.56–6.28

0.001

Age

0.99

0.96–1.01

0.293

Gender

0.89

0.31–2.52

0.825

Infections

0.79

0.39–1.59

0.506

Nephritis

0.74

0.23–2.39

0.612

Cardiac disease

1.01

0.42–2.42

0.978

Cardiovascular events

1.57

0.32–7.66

0.577

SLEDAI score

1.08

1.00–1.16

0.052

SLICC score

1.79

0.69–0.92

0.002

  1. Abbreviations: RELESSER-TRANS Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology [SER], cross-sectional phase, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC Systemic Lupus International Collaborating Clinics